See more : Joules Group Plc (JOUL.L) Income Statement Analysis – Financial Results
Complete financial analysis of Instituto Hermes Pardini S.A. (PARD3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Instituto Hermes Pardini S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- PT Dana Brata Luhur Tbk (TEBE.JK) Income Statement Analysis – Financial Results
- Crown LNG Holdings Limited (CGBS) Income Statement Analysis – Financial Results
- ICZOOM Group Inc. (IZM) Income Statement Analysis – Financial Results
- Corsa Coal Corp. (CRSXF) Income Statement Analysis – Financial Results
- Hygrovest Limited (MMJ.AX) Income Statement Analysis – Financial Results
Instituto Hermes Pardini S.A. (PARD3.SA)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.hermespardini.com.br
About Instituto Hermes Pardini S.A.
Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. It offers clinical analysis tests, diagnostic imaging, vaccines, check-ups, and other diagnostic services through 124 centers in the states of Minas Gerais, Goiás, São Paulo, and Rio de Janeiro. The company also provides lab-to-lab services, such as specialized tests for other laboratories, as well as consulting, training, and support services for its customers. It primarily operates through eight brands, which include Hermes Pardini, Progenética, Diagnóstika, Biocod, DLE, Labfar, Toxicologia Pardini, and Solução. The company serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is headquartered in Belo Horizonte, Brazil.
Source: https://incomestatements.info
Category: Stock Reports